Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 901–1,000 of 1,022
Roles of Cholesterol and Lipids in the Etiopathogenesis ofAlzheimer′s Disease
Rojo, L. E., Sjöberg-Herrera, M. K., Hernández, P., Zambrano, C. A., & Maccioni, R. B. (2006) · BioMed Research International · doi:10.1155/jbb/2006/73976 · Cited by 64
“Additionally, hypertension [47, 48], heart disease [49], obesity at midlife [50], smoking [51], elevated plasma homocysteine levels [52], diabetes [53, 54], as well as hypercholesterolemia [55, 56] are also considered as risk factors for AD.”
BackgroundGe, J., Huang, Z., Xi, Q., Yu, R., Jiang, J., & Chu, X. (2014) · Chemical Communications · doi:10.1039/c4cc05309e · Cited by 57
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Werder (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6564 · Cited by 65
“Although the upper reference limit for plasma Hcy varies according to different conditions,(17,33) plasma Hcy greater than 14 μmol/L in patients with vitamin B12 levels between 201 and 350 pg/mL suggests cellular B12 deficiency.(23,41,200,222,252,258,357,387,392) Serum B12 greater than 350 pg/mL rules out B12 deficien…”
Total Folate Content and Retention in Rosehips (Rosa ssp.) after Drying
Strålsjö, L., Alklint, C., Olsson, M. E., & Sjöholm, I. M. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034208q · Cited by 57
Genetic risk factors and markers for Alzheimer’s disease and/or depression in the VITA study
Grünblatt, E., Zehetmayer, S., Bartl, J., Löffler, C., Wichart, I., Rainer, M. K., Jungwirth, S., Bauer, P., Danielczyk, W., Tragl, K., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.008 · Cited by 63
“Therefore, a chronic deficiency in folate causes a long lasting decrease in homocystein synthesis which may be causing for the development of chronic diseases such as AD (Elias et al., 2005; Seshadri et al., 2002).”
BackgroundZhao, H., Ji, Z.-H., Liu, C., & Yu, X. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.060 · Cited by 56
“, 2008), and that there was a tight correlation between the elevated Hcy plasma levels and cognitive impairment in the elderly, AD patients and MS patients by the retrospective and prospective studies (Prins et al., 2002; Seshadri et al., 2002; Russo et al., 2008).”
Wang, L., Chen, H., Wang, H., Wang, F., Srinivasulu, K., Wang, Y., Zhao, W., & Chen, X. (2013) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2013.11.039 · Cited by 57
“[2] S.”
BackgroundSun, S., Wang, H., & Yan, X. (2011) · Chemical Communications · doi:10.1039/c0cc04463f · Cited by 57
Yang, P. H., Xu, Q., Jin, S., Zhao, Y., Lü, Y., Xu, X., & Yu, S. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102188 · Cited by 57
Zhang, Y., Zhang, W., Chen, K., Yang, Q., Hu, N., Suo, Y., & Wang, J. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.01.221 · Cited by 58
Mind the gaps: What we don't know about cognitive impairment in essential tremor
Louis, E. D., Joyce, J. L., & Cosentino, S. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.038 · Cited by 58
Levine, J., Sela, B., Osher, Y., & Belmaker, R. H. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.029 · Cited by 57
Molecular targeting by homocysteine: a mechanism for vascular pathogenesis
Jacobsen, D. W., Cătănescu, O., DiBello, P. M., & Barbato, J. C. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.188 · Cited by 66
“Homocysteine is also an emerging risk factor for Alzheimer’s disease and other disorders of cognitive function (4, 5).”
BackgroundContributors to white matter damage in the frontal lobe in Alzheimer's disease
Chalmers, K., Wilcock, G., & Love, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00678.x · Cited by 57
Green, T. J., McMahon, J. A., Skeaff, C. M., Williams, S. M., & Whiting, S. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.460 · Cited by 56
“A high circulating homocysteine concentration is an independent risk factor for several chronic conditions, including cardiovascular (1) and Alzheimer (2) disease.”
BackgroundDaulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9407-2 · Cited by 59
“It was, therefore, concluded that an increased plasma homocysteine level is indeed a strong, independent risk factor for the development of dementia/ AD (Seshadri et al. 2002).”
BackgroundZhang, W., Zhang, R., Zhang, J., Ye, Z., Jin, D., & Yuan, J. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.06.028 · Cited by 56
Zhang, M., Miao, L., Li, Y., & Hu, G. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.06.011 · Cited by 61
“Since hyperhomocysteinaemia is regarded as a risk factor of atherosclerotic disease, it may also play an important role in the development of AD (Seshadri et al., 2002).”
LSPR Sensing of Molecular Biothiols Based on Noncoupled Gold Nanorods
Li, C., Wu, C., Zheng, J., Lai, J., Zhang, C., & Zhao, Y. (2010) · Langmuir · doi:10.1021/la101285r · Cited by 56
Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review
Alam, J., & Sharma, L. K. (2018) · Current Drug Targets · doi:10.2174/1389450119666180820104723 · Cited by 58
Deep, S. N., Mitra, S., Rajagopal, S., Paul, S., & Poddar, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008820 · Cited by 56
Plasma homocysteine in obstructive sleep apnoea
Svatikova, A. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.05.018 · Cited by 56
Roles of vitamins B5, B8, B9, B12 and molybdenum cofactor at cellular and organismal levels
Rébeillé, F., Ravanel, S., Marquet, A., Mendel, R. R., Smith, A. G., & Warren, M. J. (2007) · Natural Product Reports · doi:10.1039/b703104c · Cited by 57
Serum Selenium Is Associated with Plasma Homocysteine Concentrations in Elderly Humans
González, S., Huerta, J. M., Álvarez-Uría, J., Patterson, Á. M., Lasheras, C., & Fernández, S. (2004) · Journal of Nutrition · doi:10.1093/jn/134.7.1736 · Cited by 63
“Homocysteine (tHcy)(3) is a metabolic product of methylgroup donation by the amino acid methionine; it is emerging as a risk factor for cardiovascular disease (1), Alzheimer’s disease (2), and neural tube defects (3).”
BackgroundWilson, P. W. F. (2004) · Circulation · doi:10.1161/01.cir.0000149077.87074.de · Cited by 56
Self-citationWei, W., Liu, Y.-H., Zhang, C.-E., Wang, Q., Wei, Z., Mousseau, D. D., Wang, J.-Z., Tian, Q., & Liu, G.-P. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110770 · Cited by 55
“the effect of folate and B vitamins on AD patients [6].”
InfluentialSteele, M. L., Fuller, S. L., Maczurek, A. E., Kersaitis, C., Ooi, L., & Münch, G. W. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9867-6 · Cited by 65
“An elevated plasma level of homocysteine (hyperhomocysteinemia) is recognised as an independent risk factor for a variety of chronic diseases, including AD (Dwyer et al. 2004; Li et al. 2003; Pietrzik 2006; Seshadri et al. 2002).”
Homocysteine and Cognitive Impairment
Sala, I., Sánchez‐Saudinós, M. B., Molina‐Porcel, L., Lázaro, E., Gich, I. J., Clarimón, J., Blanco‐Vaca, F., Blesa, R., Gómez‐Isla, T., & Lleó, A. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000173710 · Cited by 63
Current status of symptomatic medical therapy in Parkinson’s disease
Factor, S. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.12.001 · Cited by 50
Han, Q., Shi, Z., Tang, X., Yang, L., Mou, Z., Li, J., Shi, J., Chen, C., Liu, W., Yang, H., et al. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00463a · Cited by 55
HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain
Foti, S. B., Chou, A., Moll, A. D., & Roskams, A. J. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.03.008 · Cited by 55
“In addition, folate and vitamin B12 are essential cofactors for the methylation cycle, thus deficiencies in these nutrients also inhibit DNMTs and DNA methylation, which can cause oxidative stress and neuronal cell death (Duan et al., 2002; Kruman et al., 2002; Seshadri et al., 2002; Shea et al., 2002).”
BackgroundTu, W., Zhao, S., Liu, T., Yang, D., & Chen, H. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000228 · Cited by 62
Association of diabetes, homocysteine, and HDL with cognition and disability after stroke
Newman, G. C., Bang, H., Hussain, S. I., & Toole, J. F. (2007) · Neurology · doi:10.1212/01.wnl.0000280457.29680.9c · Cited by 61
Różycka, A., Jagodziński, P. P., Kozubski, W. P., Lianeri, M., & Dorszewska, J. (2014) · Current Genomics · doi:10.2174/1389202914666131210210559 · Cited by 60
“Thus, an elevated (greater than 14 mol/L) concentration of plasma Hcy has been reported to correlate with a doubled risk of AD [5], and has even been shown to result in lowered cognitive functions in 25% of elderly persons without dementia [9].”
BackgroundDong, H. K., Gim, J., Yeo, S. H., & Kim, H. (2016) · Gene · doi:10.1016/j.gene.2016.10.022 · Cited by 69
Liu, X., Wang, X., Han, Q., Cui, Q., Wang, C., & Yang, R. (2019) · Talanta · doi:10.1016/j.talanta.2019.05.070 · Cited by 57
Obeid, R., Kasoha, M., Knapp, J.-P., Kostopoulos, P., Becker, G., Fassbender, K. C., & Herrmann, W. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.085241 · Cited by 61
DNA damage and neurotoxicity of chronic alcohol abuse
Kruman, I. I., Henderson, G. I., & Bergeson, S. E. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011421 · Cited by 54
Zhang, Z., Wang, L., Li, G., & Ye, B. (2017) · The Analyst · doi:10.1039/c7an00415j · Cited by 54
Fiedorczuk, P., Polecka, A., Walasek, M., & Olszewska, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010060 · Cited by 57
“Disrupted homocysteine metabolism leads to hyperhomocysteinemia, a condition that has been linked in recent epidemiological studies to a higher risk of many diseases—increased HCY is a specific risk factor for cardiovascular diseases, dementia, and Alzheimer’s disease [51,52].”
Chang, Y., Chiu, G.-F., Kuo, F., Lai, C., Yang, Y.-H., Hu, H., Chang, P., Chen, C., Wu, D., & Yu, F. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/175729 · Cited by 69
“Currently, identified risk factors of AD include age, sex, plasma homocysteine level, and genetic factors like apolipoprotein E allele ε4 [3, 4].”
BackgroundFolates in fermented vegetables—a pilot study
Jägerstad, M., Jastrebova, J. A., & Svensson, U. (2004) · LWT · doi:10.1016/j.lwt.2003.11.008 · Cited by 54
“, 2002) and improved cognitive functions (Seshadri et al., 2002).”
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
Castellani, R. J., Zhu, X., Lee, H.-G., Smith, M. A., & Perry, G. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031386 · Cited by 54
“oxygen species, including traumatic brain injury, hypertensive vascular disease, diabetes mellitus, hypercholesterolemia, and hyperhomocysteinemia [80-84].”
BackgroundThe impact of vascular burden on late-life depression
Santos, M., Kövari, E., Hof, P. R., Gold, G., Bouras, C., & Giannakopoulos, P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.08.003 · Cited by 57
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo
Helman, A. M., & Murphy, M. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.009 · Cited by 60
“Additionally, although hyperhomocysteinemia is a known risk factor of stroke [122] and correlates strongly with AD [123,124], this is an independent risk factor for disease and by nomeans represents themajority of VCID cases.”
Background1,25-Dihydroxyvitamin D and Klotho
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Sabir, M. S., Khan, Z., Sandoval, R., & Jurutka, P. W. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2015.11.005 · Cited by 56
Murale, D. P., Kim, H., Choi, W. S., & Churchill, D. G. (2013) · Organic Letters · doi:10.1021/ol401480w · Cited by 54
A FRET-based near-infrared ratiometric fluorescent probe for detection of mitochondria biothiol
Wang, L., Wang, J., Xia, S., Wang, X., Yu, Y., Zhou, H., & Liu, H. (2020) · Talanta · doi:10.1016/j.talanta.2020.121296 · Cited by 53
Nelson, B. C., Pfeiffer, C. M., Sniegoski, L. T., & Satterfield, M. B. (2003) · Analytical Chemistry · doi:10.1021/ac0204799 · Cited by 57
KUO, H. ‐., Yen, C., & Bean, J. F. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01546.x · Cited by 61
Homocysteine and inflammation: Predictors of cognitive decline in older persons?
van den Kommer, T. N., Dik, M. G., Comijs, H. C., Jonker, C., & Deeg, D. J. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.009 · Cited by 53
A maleimide-based thiol fluorescent probe and its application for bioimaging
Qu, L., Yin, C., Huo, F., Li, J., Chao, J., & Zhang, Y. (2014) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.01.026 · Cited by 53
Nagendraraj, T., Priya, S. V., Annaraj, J., & Sagadevan, S. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215368 · Cited by 55
Smach, M. A., Jacob, N., Golmard, J., Charfeddine, B., Lammouchi, T., Othman, L. B., Dridi, H., Bennamou, S., & Limem, K. (2011) · European Neurology · doi:10.1159/000326301 · Cited by 57
“The decrease in the concentration of blood folate has been linked to impaired cognitive function [ , , ,”
BackgroundA turn-on NIR fluorescent probe for the detection of homocysteine over cysteine
Zhang, J., Jiang, X., Shao, X., Zhao, J., Su, Y., Xi, D., Yu, H., Yue, S., Xiao, L., & Zhao, W. (2014) · RSC Advances · doi:10.1039/c4ra08771b · Cited by 54
Micronutrient supplementation in mild Alzheimer disease patients
Planas, M., Conde, M., Audivert, S., Pérez-Portabella, C., Burgos, R., Chacón, P., Rosselló, J., Boada, M., & Tárraga, L. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00106-7 · Cited by 60
Hosseini, H., Mahyari, M., Bagheri, A., & Shaabani, A. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.08.041 · Cited by 53
“Abnormal levels of CSH are related to many diseases, such as slowed growth, Alzheimer’s disease and cardiovascular disease (Refsum et al., 1998; Seshadri et al., 2002; Ueland et al., 2004; Wang et al., 2005).”
BackgroundA fluorescent probe for differentiating Cys, Hcy and GSH via a stepwise interaction
Tian, Y., Zhu, B., Yang, W. J., Jing, J., & Zhang, X. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.01.181 · Cited by 55
Mechanism of the Condensation of Homocysteine Thiolactone with Aldehydes
Jakubowski, H. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200600785 · Cited by 53
Chanson, A., Sayd, T., Rock, E., Chambon, C., Santé-Lhoutellier, V., de Courcy, G. P., & Brachet, P. (2005) · Journal of Nutrition · doi:10.1093/jn/135.11.2524 · Cited by 57
Biofortification of folates in white wheat bread by selection of yeast strain and process
Hjortmo, S. B., Patring, J., Jastrebova, J. A., & Andlid, T. A. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.06.001 · Cited by 52
“, 1999), Alzheimer's disease (Seshadri et al., 2002) and some forms of cancer (Choi and Mason, 2000) is under thorough investigation.”
BackgroundTong, L.-L., Li, L., Chen, Z., Wang, Q., & Tang, B. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.05.051 · Cited by 54
“…levels of biothiols were related to a variety of disease, such as liver damage, skin lesions, Alzheimer's and Parkinson's diseases, cardiovascular diseases, diabetes and HIV disease (Díaz-Nido and Avila, 1990; Samiec et al., 1998; Seshadri et al., 2002; Staal et al., 1992; Weerapana et al., 2010).”
BackgroundDNA methylation in neurodegenerative disorders: a missing link between genome and environment?
Iraola-Guzmán, S., Estivill, X., & Rabionet, R. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01673.x · Cited by 52
“As both folate deficiency and high homocysteine blood levels are risk factors for AD (59, 60), MTHFD1L is an interesting candidate for further analysis.”
BackgroundVascular Risk Factors and Cognitive Decline in a Population Sample
Ganguli, M., Fu, B., Snitz, B. E., Unverzagt, F. W., Loewenstein, D., Hughes, T. F., & Chang, C.-C. H. (2013) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000004 · Cited by 56
Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Waseem Bihaqi, S., Schumacher, A., Maloney, B., K. Lahiri, D., & H. Zawia, N. (2012) · Current Alzheimer Research · doi:10.2174/156720512800617982 · Cited by 52
Brewer, G. J. (2015) · Nutrients · doi:10.3390/nu7125513 · Cited by 51
“Having an increase homocysteine blood level also increases risk of AD [22].”
BackgroundLiu, T., Huo, F., Yin, C., Li, J., Chao, J., & Zhang, Y. (2016) · Dyes and Pigments · doi:10.1016/j.dyepig.2015.12.031 · Cited by 52
Metabolic engineering of micronutrients in crop plants
Blancquaert, D., Steur, H. D., Gellynck, X., & Straeten, D. V. D. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13274 · Cited by 60
Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?
Kaufman, M. J., Kanayama, G., Hudson, J. I., & Pope, H. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.014 · Cited by 65
Chen, H., Li, R.-T., Wu, K.-Y., Hu, P.-P., Zhang, Z., Huang, N.-H., Zhang, W., & Chen, J.-X. (2019) · Talanta · doi:10.1016/j.talanta.2019.120596 · Cited by 51
Homocysteine fibrillar assemblies display cross-talk with Alzheimer’s disease β-amyloid polypeptide
Yazdi, D. S., Bar‐Yosef, D. L., Adsi, H., Kreiser, T., Sigal, S., Bera, S., Zaguri, D., Shaham‐Niv, S., Oluwatoba, D. S., Levy, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017575118 · Cited by 55
Görtz, P., Hoinkes, A., Fleischer, W., Otto, F., Schwahn, B., Wendel, U., & Siebler, M. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.11.009 · Cited by 52
“In patients with dementia, typical homocysteine concentrations are 15–30 AM [1].”
BackgroundModerate hyperhomocysteinaemia and immune activation in Parkinson's disease
Widner, B., Leblhuber, F., Frick, B., Laich, A., Artner‐Dworzak, E., & Fuchs, D. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0758-8 · Cited by 52
“…also have been observed in the blood of patients with neurodegenerative diseases such as Alzheimer’s disease and vascular dementia (Clarke et al., 1998; Leblhuber et al., 2000; Seshadri et al., 2002), and also in Parkinson’s disease (Kuhn et al., 1998; Müller et al., 1999; Yasui et al., 2000).”
BackgroundVitamin B12, folate, homocysteine and dementia: are they really related?
Arioğul, S., Cankurtaran, M., Dağli, N., Khalil, M., & Yavuz, B. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.07.005 · Cited by 51
Ray, L., Khemka, V. K., Behera, P., Bandyopadhyay, K., Pal, S., Pal, K., Basu, D., & Chakrabarti, S. (2013) · Europe PMC (PubMed Central) · Cited by 59
Dobbs, S. M., Dobbs, R. J., Weller, C., Charlett, A., Augustin, A., Taylor, D., Ibrahim, M. A. A., & Bjarnason, I. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-015-0357-8 · Cited by 51
“Low and equivocal serum B12 concentrations, and the metabolically active fraction of serum cobalamin, have been implicated (Clarke et al. 1998; Refsum and Smith 2003; Seshadri et al. 2002), but the contribution of gastric atrophy and impaired ileal absorption is unknown.”
BackgroundMa, L., Qian, J., Tian, H., Lan, M., & Zhang, W. (2012) · The Analyst · doi:10.1039/c2an35624d · Cited by 51
Allosteric Modulation of Dopamine D2 Receptors by Homocysteine
Agnati, L. F., Ferré, S., Genedani, S., Leo, G., Guidolin, D., Filaferro, M., Carriba, P., Casadó, V., Lluís, C., Franco, R., et al. (2006) · Journal of Proteome Research · doi:10.1021/pr0601382 · Cited by 56
PENN Biomarker Core of the Alzheimer’s Disease Neuroimaging Initiative
Shaw, L. M. (2008) · Neurosignals · doi:10.1159/000109755 · Cited by 51
“A large-scale community study showed that increased total homocysteine plasma concentrations up to 11 years before diagnosis are associated with an increased risk for development of dementia [”
BackgroundTwo-Input Fluorescent Probe for Thiols and Hydrogen Sulfide Chemosensing and Live Cell Imaging
Dai, C.-G., Liu, X., Du, X., Zhang, Y., & Song, Q. (2016) · ACS Sensors · doi:10.1021/acssensors.6b00291 · Cited by 53
Sacuiu, S. F. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00008-2 · Cited by 73
“This figure is in line with earlier accounts from the USA showing that dementia cases entered institutionalized care on average 2–3 years after diagnosis (Severson et al., 1994; Heyman et al., 1997).”
Liang, B., Wang, B., Ma, Q., Xie, C., Li, X., & Wang, S. (2017) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2017.10.044 · Cited by 51
Folate enhancement in staple crops by metabolic engineering
Storozhenko, S., Ravanel, S., Zhang, G., Rébeillé, F., Lambert, W. E., & Straeten, D. V. D. (2005) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2005.03.007 · Cited by 56
The transmethylation cycle in the brain of Alzheimer patients
Mulder, C., Schoonenboom, N. S. M., Jansen, E. E. W., Verhoeven‐Duif, N. M., van Kamp, G. J., Jakobs, C., & Scheltens, P. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.073 · Cited by 51
Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma
Roedl, J. B., Bleich, S., Reulbach, U., von Ahsen, N., Schlötzer-Schrehardt, U. M., Ręjdak, R., Naumann, G. O. H., Kruse, F. E., Kornhuber, J., & Jünemann, A. G. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0556-9 · Cited by 54
“, 2001), chronic neurodegenerative (den Heijer et al., 2003; Seshadri et al., 2002; Yasui et al., 2000) or vascular disease (Graham et al.”
InfluentialPathology and Pathways of Alzheimer's Disease with an Update on New Developments in Treatment
DeKosky, S. T. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.5157.x · Cited by 51
Biochemical Markers of Bone Turnover in Osteoporosis
Szulc, P., Bauer, D. C., & Eastell, R. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch35 · Cited by 62
Memantine in Moderate-to-Severe Alzheimer's Disease
Bleich, S., Wiltfang, J., & Kornhuber, J. (2003) · New England Journal of Medicine · doi:10.1056/nejm200308073490616 · Cited by 50
Chen, C.-S., Tseng, Y.-T., Hsu, Y.-Y., & Lo, Y.-C. (2013) · Neuroendocrinology · doi:10.1159/000342692 · Cited by 50
The impact of voluntary fortification of foods on micronutrient intakes in Irish adults
Hannon, E. M., Kiely, M. E., & Flynn, A. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507669207 · Cited by 50
Zhang, Y., Huo, F., Yin, C., Yue, Y., Hao, J., Chao, J., & Liu, D. (2014) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.09.091 · Cited by 50
An update on treatment and prevention strategies for Alzheimer’s disease
Neugroschl, J. A., & Sano, M. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0054-1 · Cited by 57
“Plasma homocysteine also has been evaluated as a risk factor for AD [ 31 ].”
BackgroundLi, M.-H., Tang, J., Zhang, P., Li, X., Wang, C., Wei, H., Yang, X., Zou, W., & Tang, X. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.001 · Cited by 50
Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease
Humpel, C. (2011) · World Journal of Psychiatry · doi:10.5498/wjp.v1.i1.8 · Cited by 50
Tsay, O. G., Lee, K. M., & Churchill, D. G. (2012) · New Journal of Chemistry · doi:10.1039/c2nj40387k · Cited by 51
Cunningham, R. L., Singh, M., O’Bryant, S. E., Hall, J. R., & Barber, R. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131994 · Cited by 64
“Prior studies indicate folate deficiency as a risk factor for AD and dementia [64–67].”
Is There Any Relation Between Pseudoexfoliation Syndrome and Alzheimer’s Type Dementia?
Cumurcu, T., Dorak, F., Cumurcu, B. E., Erbay, L. G., & Özsoy, E. (2013) · Seminars in Ophthalmology · doi:10.3109/08820538.2013.793726 · Cited by 56
Kapur, A., Aldeek, F., Ji, X., Safi, M., Wang, W., Cid, A. D., Steinbock, O., & Mattoussi, H. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00006 · Cited by 50
Park, A.-M., Omura, S., Fujita, M., Sato, F., & Tsunoda, I. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12401 · Cited by 59
Hou, P., Sun, J., Wang, H., Liu, L., Zou, L., & Chen, S. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127244 · Cited by 50
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.